Allarity Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $25 | $320 | $0 | $0 |
Gross Profit | 51 | 320 | -12 | |
EBITDA | -2,547 | -3,306 | -2,793 | -2,296 |
EBIT | -2,521 | -3,314 | -2,749 | -2,308 |
Net Income | -2,750 | -3,373 | -2,806 | -2,320 |
Net Change In Cash | 25 | 320 | 0 | 0 |
Free Cash Flow | -4,557 | -3,251 | -3,410 | -5,481 |
Cash | 19,812 | 14,687 | 16,895 | 17,801 |
Basic Shares | 15,968 | 14,378 | 14,739 | 15,543 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $320 | $0 | $0 | $0 |
Gross Profit | 320 | -9 | -37 | -120 |
EBITDA | -11,046 | -24,234 | -11,283 | -17,296 |
EBIT | -11,033 | -24,243 | -11,320 | -17,356 |
Net Income | -11,231 | -24,515 | -11,901 | -16,058 |
Net Change In Cash | 320 | 0 | 0 | 0 |
Cost of Revenue | -17,337 | |||
Free Cash Flow | -14,828 | -17,650 | -12,745 | -16,835 |
Cash | 14,687 | 19,533 | 166 | 2,029 |
Basic Shares | 14,378 | 1,606 | 3 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.17 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.19 |
2025-06-30 | -$0.15 |